Prestige Brands Holdings, Inc. (PBH) Analysts See $0.61 EPS

April 23, 2018 - By Hazel Jackson

Prestige Brands Holdings, Inc. (NYSE:PBH) LogoInvestors sentiment decreased to 1.12 in Q4 2017. Its down 0.52, from 1.64 in 2017Q3. It is negative, as 26 investors sold Prestige Brands Holdings, Inc. shares while 72 reduced holdings. 33 funds opened positions while 77 raised stakes. 59.33 million shares or 5.79% more from 56.08 million shares in 2017Q3 were reported.
Goldman Sachs reported 820,664 shares stake. Fisher Asset Mngmt Lc holds 1.48 million shares. Kennedy Mgmt Inc stated it has 0.25% of its portfolio in Prestige Brands Holdings, Inc. (NYSE:PBH). North Carolina-based Captrust Fin Advsr has invested 0% in Prestige Brands Holdings, Inc. (NYSE:PBH). Hutchin Hill Capital Limited Partnership holds 4,600 shares. Balyasny Asset Ltd Limited Liability Company, a Illinois-based fund reported 22,269 shares. Olstein Mgmt L P invested in 0.61% or 107,850 shares. Champlain Inv Limited Com stated it has 0.57% in Prestige Brands Holdings, Inc. (NYSE:PBH). Profund Ltd Llc stated it has 8,868 shares or 0.02% of all its holdings. Cwm Limited reported 11 shares stake. Etrade Mgmt Ltd invested in 0.04% or 25,115 shares. Aristotle Cap Boston Llc reported 319,686 shares stake. New York-based Manor Road Capital Prns Lc has invested 31.67% in Prestige Brands Holdings, Inc. (NYSE:PBH). Global X Co Ltd Liability stated it has 717 shares. Trexquant L P invested 0.12% in Prestige Brands Holdings, Inc. (NYSE:PBH).

Analysts expect Prestige Brands Holdings, Inc. (NYSE:PBH) to report $0.61 EPS on May, 10 before the open.They anticipate $0.07 EPS change or 12.96 % from last quarter’s $0.54 EPS. PBH’s profit would be $32.35M giving it 12.40 P/E if the $0.61 EPS is correct. After having $0.70 EPS previously, Prestige Brands Holdings, Inc.’s analysts see -12.86 % EPS growth. The stock decreased 1.63% or $0.5 during the last trading session, reaching $30.25. About 612,824 shares traded. Prestige Brands Holdings, Inc. (NYSE:PBH) has declined 40.38% since April 23, 2017 and is downtrending. It has underperformed by 51.93% the S&P500.

Prestige Brands Holdings, Inc. (NYSE:PBH) Ratings Coverage

Among 5 analysts covering Prestige Brand Holdings (NYSE:PBH), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Prestige Brand Holdings had 7 analyst reports since November 2, 2017 according to SRatingsIntel. As per Monday, February 5, the company rating was downgraded by DA Davidson. The stock of Prestige Brands Holdings, Inc. (NYSE:PBH) has “Outperform” rating given on Monday, December 4 by William Blair. DA Davidson downgraded Prestige Brands Holdings, Inc. (NYSE:PBH) on Friday, February 2 to “Hold” rating. The rating was maintained by Jefferies with “Hold” on Friday, February 2. Jefferies maintained Prestige Brands Holdings, Inc. (NYSE:PBH) rating on Thursday, November 2. Jefferies has “Hold” rating and $50.0 target. KeyBanc Capital Markets maintained the stock with “Overweight” rating in Monday, February 5 report. The rating was upgraded by BMO Capital Markets on Wednesday, November 15 to “Outperform”.

Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, makes, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally. The company has market cap of $1.60 billion. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning divisions. It has a 4.15 P/E ratio. The company??s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies.

Prestige Brands Holdings, Inc. (NYSE:PBH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: